Breast Radiation Device Ad Campaign Bolstered By Physician Support
This article was originally published in The Gray Sheet
Executive Summary
Physician endorsement will strengthen manufacturers direct-to-consumer marketing campaigns for new products, Cytyc marketing director Barry Hassett suggested during a recent meeting on medical device advertising and promotion
You may also be interested in...
Cytyc Pays 10-Times Sales For Proxima, Breast Cancer Therapy Market Entry
Cytyc likely will divest Proxima Therapeutics' GliaSite brain tumor radiation therapy system after acquiring the company for its MammoSite breast cancer system under a $160 mil. deal Feb. 9
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.